Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A1 | P30531 | 2/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.41 |
| ▸ | SLC6A12 | P48065 | 2/20 | 0.41 |
| ▸ | SLC6A11 | P48066 | 2/20 | 0.41 |
| ▸ | SLC6A13 | Q9NSD5 | 2/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.41 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 11/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | ANPEP | P15144 | 1/20 | 0.30 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8134719 | 0.90 | SLC6A1 (0.35) | SLC6A1GABRA5GABRB2SLC6A12SLC6A11 | |
| SCHEMBL29973085 | 0.74 | CYP2C19 (0.42) | CYP1A2 | |
| SCHEMBL28246813 | 0.68 | SLC6A1 (0.46) | SLC6A1GABRA5GABRB2SLC6A12SLC6A11 | |
| SCHEMBL3065795 | 0.67 | ANPEP (0.44) | SLC6A1GABRA5GABRB2SLC6A12SLC6A11 | |
| SCHEMBL44579 | 0.66 | GABRA5 (0.75) | SLC6A1GABRA5GABRB2SLC6A12SLC6A11 | |
| SCHEMBL361304 | 0.65 | SLC6A1 (0.50) | SLC6A1GABRA5GABRB2SLC6A12SLC6A11 | |
| Hydrochloric Acid SCHEMBL1967312 | 0.65 | GABRA5 (0.72) | SLC6A1GABRA5GABRB2SLC6A12SLC6A11 | |
| SCHEMBL16969163 | 0.64 | FFAR4 (0.50) | FFAR4FFAR1 | |
| SCHEMBL940485 | 0.63 | SLC6A1 (0.42) | SLC6A1GABRA5GABRB2SLC6A12SLC6A11 | |
| SCHEMBL939927 | 0.63 | FFAR4 (0.44) | SLC6A1GABRA5GABRB2SLC6A12SLC6A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107106709-A | Radiopharmaceutical conjugates comprising a metabolite and an EPR agent targeting tumor cells | 南非核能源有限公司 | 2017-08-29 | — | — | CN | claimed |
| WO-2000009169-A1 | NON-PORPHYRIN COMPOUND FOR USE AS A DIAGNOSTICUM AND/OR PHARMACEUTICAL | K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) | 2000-02-24 | — | — | WO | claimed |
| EP-4308584-A1 | NEW PEPTIDE-BASED DIAGNOSTIC AND THERAPEUTIC AGENTS | EnliTISA (Shanghai) Pharmaceutical Co., Ltd. (CN) | 2024-01-24 | — | — | EP | disclosed |
| CN-107106709-A | Radiopharmaceutical conjugates comprising a metabolite and an EPR agent targeting tumor cells | 南非核能源有限公司 | 2017-08-29 | — | — | CN | disclosed |
| CN-106573076-A | Library of ph responsive polymers and nanoprobes thereof | 德克萨斯大学系统董事会 | 2017-04-19 | — | — | CN | disclosed |
| EP-0956053-A4 | METHOD FOR TREATING NEOPLASIA USING HUMANIZED ANTIBODIES WHICH BIND TO ANTIGEN A33 | LUDWIG INST CANCER RES (US) | 2004-05-26 | — | — | EP | disclosed |
| EP-1011736-A2 | POLYMERS | NYCOMED IMAGING AS (NO) | 2000-06-28 | — | — | EP | disclosed |
| EP-0977600-A2 | CONTRAST AGENTS | NYCOMED IMAGING A/S (NO) | 2000-02-09 | — | — | EP | disclosed |
| EP-0956053-A1 | METHOD FOR TREATING NEOPLASIA USING HUMANIZED ANTIBODIES WHICH BIND TO ANTIGEN A33 | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1999-11-17 | — | — | EP | disclosed |
| WO-1998047541-A1 | CONTRAST AGENTS | NYCOMED IMAGING AS (NO) | 1998-10-29 | — | — | WO | disclosed |
| WO-1998032469-A2 | POLYMERS | NYCOMED IMAGING AS (NO) | 1998-07-30 | — | — | WO | disclosed |
| WO-1998022149-A1 | METHOD FOR TREATING NEOPLASIA USING HUMANIZED ANTIBODIES WHICH BIND TO ANTIGEN A33 | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1998-05-28 | — | — | WO | disclosed |